Comparison of DPP4 inhibitors versus luseogliflozin, a SGLT2 inhibitor using cotinuous glucose monitoring (CGM)
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000014333
- Lead Sponsor
- Ichinomiyanishi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
liver or renal dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CGM(BS average, SD, MAGE, M-value, AUC)
- Secondary Outcome Measures
Name Time Method